Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Thejew

V.CLAS.H

3 theories

1. A bunch of stoned penny investors picked the wrong ticker and mistakenly...

March 21, 2019

V.CLAS.H

RE:RE:RE:RE:RE:RE:aphria holds

I think it's safe to say any partnership would come out after phase2...

March 19, 2019

V.CLAS.H

RE:RE:Keep adding.

Results from the first cohort should be out any day now. Which are the lowest...

March 18, 2019

V.CLAS.H

Keep adding.

I'm still adding on these dips, up to 430K now. When this pops back into...

March 18, 2019

V.CLAS.H

RE:results..soon?

Should be any day now....Expecting them to be very good, even at the lowest...

March 12, 2019

V.CLAS.H

RE:RE: Buy Kalytera Therapeutics for a 328 per cent return:

Nope, it would have to have a disclaimer at bottom of article, which it doesn...

March 9, 2019

V.CLAS.H

News

I have a feeling inetrim data from the first cohort will be out this week or...

March 5, 2019

V.CLAS.H

News

We should be expecting news in the next week or two on the first cohort...

March 3, 2019

V.CLAS.H

RE:What are your other penny stock plays if you have any??

$ATBPF

March 1, 2019

V.CLAS.H

RE:WHATS NEXT

OS is only 216M. That's not even that bad at all, espeically consdiering...

February 26, 2019

V.CLAS.H

RE:RE:First FDA trial completed

Totally agree. Kalytera market cap is now at a ridiculousy low 11M. It's...

February 25, 2019

ATBPF

RE:RE:RE:nice to see - recognition

You're acting like almost every single small bio doesn't do the same...

February 23, 2019

V.CLAS.H

RE:The Real Deal

Based on interim results, I would hold through the final results read out...

February 17, 2019

ATBPF

Citagenix alone brought in about 10M Candian last year.

Not too shabby! Fully funded for trials now, South Korean deal details in new...

February 16, 2019

ATBPF

RE:RE:RE:RE:RE:RE:RE:RE:RE:DOCS are out ..

Your acting like almost every small bio doesn't do the exact same thing...

February 16, 2019

ATBPF

RE:RE:RE:RE:RE:RE:RE:RE:DOCS are out ..

What are you talking about? They got a great licensing deal in Korea and the...

February 16, 2019

V.CLAS.H

RE:Nothing

How is there too many shares? ONly 294M OS. That's not that many at all...

February 8, 2019

V.CLAS.H

RE:RE:RE:Another news release timed...

Excellent news! Wow. Amazing to see these interim results coming out. The...

February 5, 2019

V.CLAS.H

RE:Stockhunter100 Making False Statements

It happens all the time on that site. It's a Gov. site FFS haha The same...

January 28, 2019

V.CLAS.H

Relax guys.

This stock is like every other bio stock, yes it needs news to move. Phase 2...

January 24, 2019

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 Next

Featured Company

Theralase Technologies Inc.

Theralase Technologies Inc. V.TLT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ... view more »